Diol (meth) acrylate compound having urethane bond, method for producing the same, and polymer thereof
申请人:Kang Eui-chul
公开号:US20060089473A1
公开(公告)日:2006-04-27
The present invention provides compounds having in their molecule a structure contributing to high hydrophilicity, and having high photopolymerizability, as well as polymers of such compounds, and a method for producing the compound. The compounds are diol (meth)acrylate having a urethane bond represented by the formula (1), and cyclic ketal (meth)acrylate having a urethane bond represented by the formula (2):
(R
1
: H, —CH
3
; R
2
: —(CH
2
)n-; R
3
: —(CH
2
)m-; n: 1-4; m: 1-8; (AO) : C2-C4 oxyalkylene group; x: 0-1000; R
4
, R
5
: H, —CH
3
, —C
2
H
5
).
[EN] MACROPHAGE MIGRATION INHIBITORY FACTOR INHIBITORS, AND METHODS OF MAKING AND USING SAME<br/>[FR] INHIBITEURS DU FACTEUR INHIBITEUR DE LA MIGRATION DES MACROPHAGES, ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION
申请人:UNIV YALE
公开号:WO2022093817A1
公开(公告)日:2022-05-05
The present disclosure provides inhibitors of MIF tautomerase activity. In certain embodiments, the compounds inhibitors are useful in treating or preventing inflammatory and/or auto-immune diseases. In other embodiments, the compounds are useful in reversing, ameliorating, and/or preventing tumor growth. In yet other embodiments, the compounds are useful in reversing, ameliorating, and/or preventing angiogenesis.
DIOL (METH) ACRYLATE COMPOUND HAVING URETHANE BOND, METHOD FOR PRODUCING THE SAME, AND POLYMER THEREOF
申请人:Kang Eui-chul
公开号:US20090240015A1
公开(公告)日:2009-09-24
The present invention provides compounds having in their molecule a structure contributing to high hydrophilicity, and having high photopolymerizability, as well as polymers of such compounds, and a method for producing the compound. The compounds are diol (meth)acrylate having a urethane bond represented by the formula (1), and cyclic ketal (meth)acrylate having a urethane bond represented by the formula (2):
(R
1
: H, —CH
3
; R
2
: —(CH
2
)n-; R
3
: —(CH
2
)m-; n: 1-4; m: 1-8; (AO): C2-C4 oxyalkylene group; x: 0-1000; R
4
, R
5
: H, —CH
3
, —C
2
H
5
).
A macrolide compound represented by the formula (I) effective against erythromycin resistant bacteria (for example, resistant pneumococci, streptococci and mycoplasmas).